Keywords: genzyme, profit, down, costs, biotechnology, major, fell

Genzyme's 2008 profit down on costs

Article | 23 February 2009

Print This

US biotechnology major Genzyme's profit for 2008 fell 12% year-on-year, due to rocketing expenses, particularly relating to R&D costs.

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in